Target Name: COL10A1
NCBI ID: G1300
Review Report on COL10A1 Target / Biomarker Content of Review Report on COL10A1 Target / Biomarker
COL10A1
Other Name(s): Alpha 1 Type X collagen (COL10A1) | OTTHUMP00000040411 | collagen X, alpha-1 polypeptide | COAA1_HUMAN | OTTHUMP00000017049 | Schmid metaphyseal chondrodysplasia | Collagen alpha-1(X) chain | Collagen type X alpha 1 chain | Collagen X, alpha-1 polypeptide | collagen type X alpha 1 chain | collagen, type X, alpha 1

Exploring the Potential Applications of COL10A1 as a Drug Target and Biomarker

Introduction

Collagen is a protein that plays a crucial role in the structure and integrity of tissues, including skin, bones, and connective tissues. It is composed of multiple types,伪2,伪1,伪9, and COL10A1, which are known as Type X collagen. type As an important molecule, it has broad application prospects in the field of biomedicine. This article focuses on introducing COL10A1 as a drug target and biomarker, and explores its clinical application value.

1. Biological functions of COL10A1

COL10A1 is a member of the 伪1 type collagen family and is mainly found in human connective tissue, ligaments, tendons, skin, blood vessels and lung tissue. COL10A1 has multiple biological functions, including:

1. Structural support: COL10A1 is a key protein connecting tissues, organs and bones, providing support for maintaining the shape, structure and function of tissues and organs.

2. Mechanical strength: COL10A1 has high mechanical strength, which can support and protect internal organs and prevent organ damage.

3. Cell adhesion: COL10A1 can bind to glycoproteins on a variety of cell surfaces, thereby promoting cell adhesion, migration and proliferation, and plays an important role in the fields of tissue engineering and regenerative medicine.

4. Inflammatory response: COL10A1 can regulate inflammatory response and has potential clinical significance for tissue damage and disease treatment.

5. Antioxidant: COL10A1 has antioxidant effects and can scavenge free radicals in the body, reduce oxidative stress, and delay the aging process.

2. COL10A1 as a drug target

1. Anti-tumor activity: COL10A1 has anti-tumor activity and inhibits the growth and spread of tumor cells by regulating cell cycle, proliferation and apoptosis. Clinical studies have shown that the anti-tumor activity of COL10A1 is related to its biological activity and is expected to become a potential tumor treatment target.

2. Immune regulation: COL10A1 can regulate the function of immune cells, such as the activation, proliferation and differentiation of T cells, B cells and macrophages. This provides a theoretical basis for using COL10A1 as an immune regulatory target and opens up a new direction for immunotherapy.

3. Anti-inflammatory effect: COL10A1 has anti-inflammatory effect, which can reduce the inflammatory response and reduce the patient's pain level. Therefore, COL10A1 is expected to become a target for anti-inflammatory drugs.

4. Neuroprotection: COL10A1 has a protective effect in neural tissue and can promote the growth and regeneration of nerve cells. Therefore, COL10A1 serves as a divine

Protein Name: Collagen Type X Alpha 1 Chain

Functions: Type X collagen is a product of hypertrophic chondrocytes and has been localized to presumptive mineralization zones of hyaline cartilage

The "COL10A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COL10A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

COL11A1 | COL11A2 | COL11A2P1 | COL12A1 | COL13A1 | COL14A1 | COL15A1 | COL16A1 | COL17A1 | COL18A1 | COL18A1-AS1 | COL19A1 | COL1A1 | COL1A2 | COL1A2-AS1 | COL20A1 | COL21A1 | COL22A1 | COL23A1 | COL24A1 | COL25A1 | COL26A1 | COL27A1 | COL28A1 | COL2A1 | COL3A1 | COL4A1 | COL4A2 | COL4A2-AS1 | COL4A3 | COL4A4 | COL4A5 | COL4A6 | COL5A1 | COL5A2 | COL5A3 | COL6A1 | COL6A2 | COL6A3 | COL6A4P1 | COL6A4P2 | COL6A5 | COL6A6 | COL7A1 | COL8A1 | COL8A2 | COL9A1 | COL9A2 | COL9A3 | COLCA1 | COLEC10 | COLEC11 | COLEC12 | COLGALT1 | COLGALT2 | Colipase-Lipase complex | Collagen | Collagen alpha-1(I) chain | Collagen I | Collagen IV | Collagen IX | Collagen V | Collagen VI | Collagen VIII | Collagen XI | Collagenase | Colony-stimulating factor | COLQ | COMETT | COMMD1 | COMMD10 | COMMD2 | COMMD3 | COMMD3-BMI1 | COMMD4 | COMMD5 | COMMD6 | COMMD7 | COMMD8 | COMMD9 | COMP | Complement Complex | Complement component 1q | Complement component C1 | Complement component C8 | COMT | COMTD1 | Condensin complex | Condensin-2 complex | Conserved oligomeric Golgi complex | COP1 | COP9 signalosome complex | COPA | COPB1 | COPB2 | COPB2-DT | COPE | COPG1 | COPG2 | COPG2IT1